GGrantIndex
Sort

53,477 grants matching addiction

Single nuclei transcriptome profiling in addiction circuitry of the HIV+ brain

$794,264
Schahram Akbarian · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · DA

A STUDY OF ANESTHESIA-ASSISTED HEROIN DETOXIFICATION

$794,245
New York State Psychiatric Institute · R01 · FY2001 · DA

Probing brain circuit and behavior with protein:protein interaction modulators

$794,232
Fernanda Laezza · University Of Texas Med Br Galveston · R01 · FY2024 · MH

Probing brain circuit and behavior with protein:protein interaction modulators

$794,232
Fernanda Laezza · University Of Texas Med Br Galveston · R01 · FY2025 · MH

Project 1 - Clinical Trials

$794,173
Jed E Rose · Duke University · P50 · FY2017 · DA

Project 1 - Clinical Trials

$794,173
Jed E Rose · Duke University · P50 · FY2015 · DA

Project 1 - Clinical Trials

$794,173
Jed E Rose · Duke University · P50 · FY2019 · DA

Effectiveness of a CBT-based mHealth Intervention Targeting MOUD Retention, Adherence, and Opioid Use

$794,148
Suzette V Glasner-Edwards · University Of California Los Angeles · R33 · FY2021 · AT

Molecular Genetic Bases for Quit Success

$793,919
George Uhl · National Institute On Drug Abuse · Z01 · FY2007 · DA

The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network

$793,806
Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2015 · DA

Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.

$793,652
Nigel T Maidment · University Of California Los Angeles · UH3 · FY2022 · TR

Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.

$793,584
Nigel T Maidment · University Of California Los Angeles · UH3 · FY2023 · TR

Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.

$793,584
Nigel T Maidment · University Of California Los Angeles · UH3 · FY2024 · TR

Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.

$793,444
Todd C. Skaar · Indiana University Indianapolis · U01 · FY2021 · HG

Preventing prescription opioid misuse among employees working in high risk industries.

$793,409
Stephen Hebard · Prevention Strategies, Llc · R44 · FY2023 · DA

NATIONAL ADDICTION AND HEALTH DATA ARCHIVE PROGRAM. PERIOD OF PERFORMANCE APRIL 1, 2024 - MARCH 31, 2026.

$793,285
University Of Michigan At Ann Arbor · N01 · FY2025 · DA

Digital, Community-Led, Social Action Initiative to Reduce Opioid Vulnerability and HIV/HCV in Rural Areas of the Midwest and Appalachia

$793,000
Dolores Albarracin · University Of Illinois At Urbana-Champaign · DP1 · FY2019 · DA

Digital, Community-Led, Social Action Initiative to Reduce Opioid Vulnerability and HIV/HCV in Rural Areas of the Midwest and Appalachia

$793,000
Dolores Albarracin · University Of Illinois At Urbana-Champaign · DP1 · FY2020 · DA

Opioid Overdoses among Medicaid Beneficiaries: Predictors, Outcomes, and State Policy Effects

$792,856
Stephen Crystal · Rutgers, The State Univ Of N.J. · R01 · FY2022 · DA

Environmental Tobacco Smoke Reduction in Preteens

$792,738
San Diego State University · R01 · FY2005 · HL

Clinical and Genetic Study of Prescription Opioid Addiction

$792,666
Vanessa Troiani · Geisinger Clinic · R01 · FY2020 · DA

Johnny Bee Good: Bees as Models to Study the Hijacking of the Reward System

$792,500
Gene E Robinson · University Of Illinois At Urbana-Champaign · DP1 · FY2010 · OD

Johnny Bee Good: Bees as Models to Study the Hijacking of the Reward System

$792,500
Gene E Robinson · University Of Illinois At Urbana-Champaign · DP1 · FY2009 · OD

Immunopharmacotherapy for Mitigating Opioid Addiction

$792,470
Kim D Janda · Scripps Research Institute, The · UH2 · FY2015 · DA

Fast-track: Scalable digital delivery of evidence-based training for addiction professionals to maximize treatment admission and retention rates of opioid use disorder in affected families.

$792,422
Jane Macky · We The Village, Inc. · R44 · FY2025 · DA